Background: An epimeric form of 25-hydroxyvitamin D 3 (25(OH)D 3 ) has recently been detected in clinical samples, with relatively high levels in infants. Little is known on 3-epi-25(OH) D 3 formation and physiological function. Our objective was to study dynamics of 3-epi-25(OH)D 3 formation during infancy. Methods: 25(OH)D 3 and 3-epi-25(OH)D 3 levels were measured by liquid chromatography-tandem mass spectrometry in 22 preterm (aged 34-37 wk), 15 early preterm (aged <34 wk), and 118 term infants up to 2 y of age. All infants were prescribed vitamin D 400 IU/day after the first week of life. results: At birth, 3-epi-25(OH)D 3 levels were 3 (1-7) nmol/l, <10% of total 25(OH)D 3 . From the second week to 3 mo of age, both 25(OH)D 3 and 3-epi-25(OH)D 3 increased, with highest 3-epi-25(OH)D 3 contribution in early preterm infants (up to 55% of total 25(OH)D 3 vs. 36% in term infants, P < 0.0001). After 3 mo of age, 3-epi-25(OH)D 3 normalized to <10% in all infants. conclusions: At birth, all infants showed low contribution of 3-epi-25(OH)D 3 , increasing the week after starting vitamin D supplementation, until 3 mo of age. Highest levels of 3-epi-25(OH)D 3 were found in early preterm infants, supporting the hypothesis that hepatic immaturity plays a role in 3-epi-25(OH) D 3 formation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.